Liang Peng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Liang Peng has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Bo Huang
College of Acupuncture and Tuina and Rehabilitation, Hunan University of Chinese Medicine, China
3 shared publications- Haihua Xie
College of Acupuncture & Tuina and Rehabilitation, Hunan University of Chinese Medicine, 410208 Changsha, Hunan, China
3 shared publications - Mi Liu
School of Acupuncture-moxibustion, Tuina and Rehabilitation, Hunan University of Chinese Medicine, Changsha, China
3 shared publications Jia Jiang
College of Acupuncture and Tuina and Rehabilitation, The Second Affiliated Hospital of Hunan University of Chinese Medicine
2 shared publicationsSihui Cao
College of Acupuncture and Tuina and Rehabilitation, Hunan University of Chinese Medicine
2 shared publications- Bo Huang
School of Acupuncture & Tuina and Rehabilitation, Hunan University of Chinese Medicine, Changsha 410208, China
1 shared publication
Latest Publications
- Open Access
- 17 April 2026
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 99, 103381
Tuina for chronic non-specific low back pain: A systematic review and meta-analysis of randomized controlled trials
- 17 April 2026
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 99, 103381
Open AccessTuina for chronic non-specific low back pain: A systematic review and meta-analysis of randomized controlled trials
- Open Access
- 18 December 2025
- Published by Taylor & Francis in Annals of Medicine
- Vol. 57 (1) , 2600749
Impact of repetitive transcranial magnetic stimulation combined with traditional Chinese Tuina for stroke: a systematic review and meta-analysis
Stroke has emerged as one of the leading causes of long-term disability worldwide. Although the therapeutic effects of traditional Chinese Tuina and rTMS as monotherapies have been partially established, research on their combined application in stroke rehabilitation remains limited. This meta-analysis aims to investigate the effects of traditional Chinese Tuina combined with rTMS for stroke. Nine databases, including EMBASE, PubMed, Cochrane Central Register of Controlled Trials, Web of Science, Alternative HealthWatch, VIP, Wanfang, CNKI and the Chinese Biomedical Literature Database, were searched from inception to August 5, 2025. Two authors independently performed literature screening, data extraction, and risk-of-bias assessment. Meta-analysis was conducted using STATA software. Eleven studies involving 1,134 patients were included in this meta-analysis. The meta-analysis indicated that, compared to the control group, the intervention group demonstrated significantly higher motor function scores [p < 0.001] and life quality [p < 0.001]. The intervention group also exhibited lower depression scores [p < 0.001] and sleep scores [p < 0.001]. The meta-regression analysis results showed that coil type had a significant impact on quality of life [p < 0.001]; session count and stimulation frequency independently had a marginally significant impact on motor function [p = 0.09 < 0.1]; and quality of life [p = 0.06 < 0.1]. Subgroup analysis suggested that 24 rTMS sessions may yield the most favourable improvement in motor function for post-stroke patients [p < 0.001], while low-frequency and 8-coil demonstrate optimal efficacy in enhancing patients' quality of life [p < 0.001; p < 0.001]. No publication bias was detected across the analyses. The combination of rTMS and Tuina significantly improves motor function, enhances quality of life, alleviates depressive symptoms, and improves sleep quality for stroke. 24 rTMS sessions may yield the most favourable improvement in motor function. Moreover, low-frequency and 8-coil demonstrate optimal efficacy in enhancing patients' quality of life.
- 18 December 2025
- Published by Taylor & Francis in Annals of Medicine
- Vol. 57 (1) , 2600749
Open AccessImpact of repetitive transcranial magnetic stimulation combined with traditional Chinese Tuina for stroke: a systematic review and meta-analysis
Stroke has emerged as one of the leading causes of long-term disability worldwide. Although the therapeutic effects of traditional Chinese Tuina and rTMS as monotherapies have been partially established, research on their combined application in stroke rehabilitation remains limited. This meta-analysis aims to investigate the effects of traditional Chinese Tuina combined with rTMS for stroke. Nine databases, including EMBASE, PubMed, Cochrane Central Register of Controlled Trials, Web of Science, Alternative HealthWatch, VIP, Wanfang, CNKI and the Chinese Biomedical Literature Database, were searched from inception to August 5, 2025. Two authors independently performed literature screening, data extraction, and risk-of-bias assessment. Meta-analysis was conducted using STATA software. Eleven studies involving 1,134 patients were included in this meta-analysis. The meta-analysis indicated that, compared to the control group, the intervention group demonstrated significantly higher motor function scores [p < 0.001] and life quality [p < 0.001]. The intervention group also exhibited lower depression scores [p < 0.001] and sleep scores [p < 0.001]. The meta-regression analysis results showed that coil type had a significant impact on quality of life [p < 0.001]; session count and stimulation frequency independently had a marginally significant impact on motor function [p = 0.09 < 0.1]; and quality of life [p = 0.06 < 0.1]. Subgroup analysis suggested that 24 rTMS sessions may yield the most favourable improvement in motor function for post-stroke patients [p < 0.001], while low-frequency and 8-coil demonstrate optimal efficacy in enhancing patients' quality of life [p < 0.001; p < 0.001]. No publication bias was detected across the analyses. The combination of rTMS and Tuina significantly improves motor function, enhances quality of life, alleviates depressive symptoms, and improves sleep quality for stroke. 24 rTMS sessions may yield the most favourable improvement in motor function. Moreover, low-frequency and 8-coil demonstrate optimal efficacy in enhancing patients' quality of life.
- Open Access
Repetitive transcranial magnetic stimulation in conjunction with scalp acupuncture in treating poststroke cognitive impairment: a protocol for systematic review and meta-analysis
Introduction Approximately 70% of patients with stroke experience varying degrees of cognitive impairment, which imposes a substantial direct and indirect socioeconomic burden. Previous studies have shown that scalp acupuncture (SA) or repetitive transcranial magnetic stimulation (rTMS) in combination with other therapies is effective for poststroke cognitive impairment (PSCI). Limited by interstudy heterogeneity and the limited number of included studies, there is insufficient evidence of the efficacy of rTMS in combination with SA in treating PSCI. Therefore, this protocol aims to investigate the effectiveness of rTMS in conjunction with SA for patients with PSCI through a comprehensive meta-analysis. Methods and analysis This study will undertake a comprehensive search across nine distinct databases (Web of Science, Embase, Cochrane Library, PubMed, China National Knowledge Infrastructure, Wanfang Data, China Science and Technology Journal Database, China Biology Medicine and SCOPUS). The primary outcome will encompass the Montreal Cognitive Assessment and the Mini-Mental State Examination. The secondary outcomes are the modified Barthel Index, the Rivermead Behavioral Memory Test and the Digit Span Test. The bias risk assessment tool from the Cochrane Handbook for Systematic Reviews of Interventions will be used to evaluate bias risk, and the GRADE will be applied to gauge the quality of evidence. Furthermore, we plan to perform an analysis of subgroups to investigate the heterogeneity, employ the leave-one-out approach for sensitivity evaluation and use funnel plots and Egger’s test to determine publication bias, respectively. Ethics and dissemination Ethical approval is not required in systematic review and meta-analysis. The review will be published in a peer-reviewed journal. PROSPERO registration number CRD42024571762.
Open AccessRepetitive transcranial magnetic stimulation in conjunction with scalp acupuncture in treating poststroke cognitive impairment: a protocol for systematic review and meta-analysis
Introduction Approximately 70% of patients with stroke experience varying degrees of cognitive impairment, which imposes a substantial direct and indirect socioeconomic burden. Previous studies have shown that scalp acupuncture (SA) or repetitive transcranial magnetic stimulation (rTMS) in combination with other therapies is effective for poststroke cognitive impairment (PSCI). Limited by interstudy heterogeneity and the limited number of included studies, there is insufficient evidence of the efficacy of rTMS in combination with SA in treating PSCI. Therefore, this protocol aims to investigate the effectiveness of rTMS in conjunction with SA for patients with PSCI through a comprehensive meta-analysis. Methods and analysis This study will undertake a comprehensive search across nine distinct databases (Web of Science, Embase, Cochrane Library, PubMed, China National Knowledge Infrastructure, Wanfang Data, China Science and Technology Journal Database, China Biology Medicine and SCOPUS). The primary outcome will encompass the Montreal Cognitive Assessment and the Mini-Mental State Examination. The secondary outcomes are the modified Barthel Index, the Rivermead Behavioral Memory Test and the Digit Span Test. The bias risk assessment tool from the Cochrane Handbook for Systematic Reviews of Interventions will be used to evaluate bias risk, and the GRADE will be applied to gauge the quality of evidence. Furthermore, we plan to perform an analysis of subgroups to investigate the heterogeneity, employ the leave-one-out approach for sensitivity evaluation and use funnel plots and Egger’s test to determine publication bias, respectively. Ethics and dissemination Ethical approval is not required in systematic review and meta-analysis. The review will be published in a peer-reviewed journal. PROSPERO registration number CRD42024571762.
- Open Access
- 6 February 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (3) , 1373
The Role of Gut Microbiota-Derived Trimethylamine N-Oxide in the Pathogenesis and Treatment of Mild Cognitive Impairment
Mild cognitive impairment (MCI) represents a transitional stage between normal aging and dementia, often considered critical for dementia prevention. Despite its significance, no effective clinical treatment for MCI has yet been established. Emerging evidence has demonstrated a strong association between trimethylamine-N-oxide (TMAO), a prominent metabolite derived from the gut microbiota, and MCI, highlighting its potential as a biomarker and therapeutic target. TMAO has been implicated in increasing MCI risk through its influence on factors such as hypertension, cardiovascular disease, depression, diabetes, and stroke. Moreover, it contributes to MCI by promoting oxidative stress, disrupting the blood–brain barrier, impairing synaptic plasticity, inducing inflammation, causing mitochondrial metabolic disturbances, and facilitating abnormal protein aggregation. This review further explores therapeutic strategies targeting TMAO to mitigate MCI progression.
- 6 February 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (3) , 1373
Open AccessThe Role of Gut Microbiota-Derived Trimethylamine N-Oxide in the Pathogenesis and Treatment of Mild Cognitive Impairment
Mild cognitive impairment (MCI) represents a transitional stage between normal aging and dementia, often considered critical for dementia prevention. Despite its significance, no effective clinical treatment for MCI has yet been established. Emerging evidence has demonstrated a strong association between trimethylamine-N-oxide (TMAO), a prominent metabolite derived from the gut microbiota, and MCI, highlighting its potential as a biomarker and therapeutic target. TMAO has been implicated in increasing MCI risk through its influence on factors such as hypertension, cardiovascular disease, depression, diabetes, and stroke. Moreover, it contributes to MCI by promoting oxidative stress, disrupting the blood–brain barrier, impairing synaptic plasticity, inducing inflammation, causing mitochondrial metabolic disturbances, and facilitating abnormal protein aggregation. This review further explores therapeutic strategies targeting TMAO to mitigate MCI progression.